"Tildacerfont for the treatment of patients with classic congenital adrenal hyperplasia: results from a 12-week phase 2 clinical trial in adults with classic CAH" by Richard Auchus

Selected Works of Samer Nakhle, MD, FACE

Article

Tildacerfont for the treatment of patients with classic congenital adrenal hyperplasia: results from a 12-week phase 2 clinical trial in adults with classic CAH

23rd European Congress of Endocrinology (ECE 2021) (2021)

Richard Auchus
Deborah Merke
Madu Ivy-Joan
Samer Nakhle
Kyriakie Sarafoglou
Michael Huang
David Moriarty
Chris Barnes
Ron Newfield

Link

Disciplines

Medicine and Health Sciences and
Pediatrics

Publication Date

May 15, 2021

DOI

10.1530/ENDOABS.73.PEP1.2

Citation Information

Richard Auchus, Deborah Merke, Madu Ivy-Joan, Samer Nakhle, et al.. "Tildacerfont for the treatment of patients with classic congenital adrenal hyperplasia: results from a 12-week phase 2 clinical trial in adults with classic CAH" 23rd European Congress of Endocrinology (ECE 2021) Vol. 73 (2021)
Available at: http://works.bepress.com/samer-nakhle/5/